34,363 Shares in Clover Health Investments, Corp. (NASDAQ:CLOV) Acquired by HighTower Advisors LLC

HighTower Advisors LLC purchased a new stake in Clover Health Investments, Corp. (NASDAQ:CLOV) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 34,363 shares of the company’s stock, valued at approximately $97,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC bought a new stake in shares of Clover Health Investments in the third quarter valued at about $28,000. Sigma Planning Corp acquired a new stake in Clover Health Investments in the 3rd quarter worth about $29,000. Viewpoint Capital Management LLC boosted its holdings in Clover Health Investments by 96.8% in the 2nd quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company’s stock valued at $38,000 after purchasing an additional 15,000 shares during the period. Vanguard Personalized Indexing Management LLC grew its position in shares of Clover Health Investments by 54.4% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company’s stock worth $42,000 after purchasing an additional 12,104 shares in the last quarter. Finally, Realta Investment Advisors bought a new position in shares of Clover Health Investments during the third quarter worth approximately $44,000. 19.77% of the stock is owned by institutional investors and hedge funds.

Clover Health Investments Stock Up 3.8 %

CLOV stock opened at $3.31 on Friday. The company’s 50-day moving average price is $3.51 and its two-hundred day moving average price is $2.73. Clover Health Investments, Corp. has a 12 month low of $0.61 and a 12 month high of $4.71. The firm has a market cap of $1.66 billion, a P/E ratio of -16.55 and a beta of 1.94.

Clover Health Investments (NASDAQ:CLOV) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.01. The business had revenue of $330.99 million during the quarter, compared to the consensus estimate of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same period in the previous year, the business earned ($0.09) earnings per share. Equities analysts predict that Clover Health Investments, Corp. will post -0.12 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CLOV. Craig Hallum initiated coverage on Clover Health Investments in a research note on Tuesday, December 17th. They issued a “buy” rating and a $6.00 price target for the company. UBS Group began coverage on Clover Health Investments in a research report on Monday, October 7th. They set a “neutral” rating and a $4.00 target price for the company.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.